133 related articles for article (PubMed ID: 1336919)
1. Lupus anticoagulant and anticardiolipin antibodies in an obstetric population.
Rix P; Stentoft J; Aunsholt NA; Dueholm M; Tilma KA; Høier-Madsen M
Acta Obstet Gynecol Scand; 1992 Dec; 71(8):605-9. PubMed ID: 1336919
[TBL] [Abstract][Full Text] [Related]
2. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
Alving BM; Barr CF; Tang DB
Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
[TBL] [Abstract][Full Text] [Related]
3. Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death.
Al Jameil N; Tyagi P; Al Shenefy A
Int J Clin Exp Pathol; 2015; 8(3):3204-9. PubMed ID: 26045841
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies among pregnant women with recurrent fetal wastage in a tertiary hospital in Northern Nigeria.
Abdullahi ZG; Abdul MA; Aminu SM; Musa BO; Amadu L; Jibril el-BM
Ann Afr Med; 2016; 15(3):133-7. PubMed ID: 27549418
[TBL] [Abstract][Full Text] [Related]
5. Lupus anticoagulant and anticardiolipin antibodies in polytransfused beta thalassemia major.
Sharma S; Raina V; Chandra J; Narayan S; Sharma S
Hematology; 2006 Aug; 11(4):287-90. PubMed ID: 17178669
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant.
Nielsen HS; Christiansen OB
Hum Reprod; 2005 Jun; 20(6):1720-8. PubMed ID: 15774545
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of various antiphospholipid antibodies in pregnant women.
Fialová L; Mikulíková L; Matous-Malbohan I; Benesová O; Zwinger A
Physiol Res; 2000; 49(3):299-305. PubMed ID: 11043916
[TBL] [Abstract][Full Text] [Related]
8. Determination of clinically significant tests for antiphospholipid antibodies and cutoff levels for obstetric antiphospholipid syndrome.
Kitaori T; Sugiura-Ogasawara M; Oku K; Papisch W; Ebara T; Ozaki Y; Katano K; Atsumi T
Lupus; 2015 Dec; 24(14):1505-19. PubMed ID: 26162683
[TBL] [Abstract][Full Text] [Related]
9. Beta2-glycoprotein I dependent anticardiolipin antibodies and lupus anticoagulant in patients with recurrent pregnancy loss.
Kumar KS; Jyothy A; Prakash MS; Rani HS; Reddy PP
J Postgrad Med; 2002; 48(1):5-10. PubMed ID: 12082318
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population.
Lockwood CJ; Romero R; Feinberg RF; Clyne LP; Coster B; Hobbins JC
Am J Obstet Gynecol; 1989 Aug; 161(2):369-73. PubMed ID: 2504043
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura.
Stasi R; Stipa E; Masi M; Oliva F; Sciarra A; Perrotti A; Olivieri M; Zaccari G; Gandolfo GM; Galli M
Blood; 1994 Dec; 84(12):4203-8. PubMed ID: 7994034
[TBL] [Abstract][Full Text] [Related]
12. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies in young myocardial infarction patients.
Mishra MN; Kalra R; Gupta MK
Indian J Biochem Biophys; 2007 Dec; 44(6):481-4. PubMed ID: 18320848
[TBL] [Abstract][Full Text] [Related]
14. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
[TBL] [Abstract][Full Text] [Related]
15. Obstetric outcome in antiphospholipid syndrome.
Granger KA; Farquharson RG
Lupus; 1997; 6(6):509-13. PubMed ID: 9256308
[TBL] [Abstract][Full Text] [Related]
16. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
17. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).
Ordi-Ros J; Pérez-Pemán P; Monasterio J
Haemostasis; 1994; 24(3):165-74. PubMed ID: 7988946
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects.
Vila P; Hernández MC; López-Fernández MF; Batlle J
Thromb Haemost; 1994 Aug; 72(2):209-13. PubMed ID: 7831653
[TBL] [Abstract][Full Text] [Related]
19. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G
Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420
[TBL] [Abstract][Full Text] [Related]
20. Anticardiolipin antibody in women with recurrent spontaneous miscarriage.
Jwad IM; Mahdi NK; Flafil MS
Saudi Med J; 2006 Sep; 27(9):1387-90. PubMed ID: 16951778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
